Stanozolol (Winstrol): Liver, Lipid, and Cardiovascular Risks

Understanding stanozolol side effects requires examining its pharmacological properties and interactions with several physiological systems. Stanozolol, commonly associated with the name Winstrol, is a synthetic anabolic-androgenic steroid. Its biological activity involves androgen receptors and pathways related to protein metabolism.

Its clinical and pharmacological profile includes important considerations involving liver function, blood lipids, and cardiovascular health. These areas deserve attention when examining the compound’s characteristics and available scientific evidence.

At Vpharma Lab, we approach anabolic compounds through their mechanisms, clinical context, and documented research. This article explores stanozolol liver effects, cholesterol changes, and cardiovascular considerations using available scientific literature.

What Is Stanozolol (Winstrol)?

Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone (DHT). It belongs to the 17α-alkylated steroid family, a structural modification associated with oral activity.

The compound is commonly known by its historical brand name, Winstrol. Pharmaceutical presentations have included oral tablets and injectable formulations.

Stanozolol interacts with androgen receptors and influences biological pathways associated with anabolic activity. Its molecular structure distinguishes it from testosterone esters and several other anabolic compounds.

How Does Stanozolol Work?

Stanozolol acts through androgen receptor signaling. After binding to these receptors, it influences gene expression and protein-related cellular processes.

Its anabolic and androgenic characteristics reflect this interaction. However, its effects depend on individual physiology and other biological factors.

Stanozolol’s 17α-alkylated structure is an important characteristic when examining its pharmacological profile. This modification supports oral activity and helps explain its relationship with hepatic metabolism.

For additional information about related compounds, read our article on Dianabol (Methandrostenolone): Health Risks, Liver Effects, and Medical Context.

Stanozolol and Liver Function

One important area of research involving stanozolol liver toxicity concerns its relationship with hepatic metabolism and bile processing.

Stanozolol belongs to a structural class of anabolic steroids associated with characteristic patterns of liver injury. The 17α-alkylation modification helps explain this relationship.

Understanding Hepatic Metabolism

The liver participates in processing medications and regulating several metabolic pathways. Stanozolol’s molecular structure influences how the compound interacts with hepatic metabolism.

Research on 17α-alkylated anabolic steroids describes different patterns of hepatic responses. These include changes in liver enzymes and cholestatic presentations.

Cholestatic Liver Effects

Cholestasis involves changes in bile formation or flow. It can influence bilirubin processing and produce recognizable clinical and laboratory findings.

A study published in 2025 examined 18 cases of stanozolol-induced liver injury. Researchers identified a characteristic pattern involving increased bilirubin and comparatively modest changes in certain liver enzymes.

Pruritus and jaundice were among the reported clinical findings. The average time between exposure and symptom onset was approximately 55 days.

Importantly, this case series describes selected clinical cases. It does not establish the incidence of liver injury among all individuals exposed to Stanozolol.

Liver Function Measurements

Clinical assessment may include several laboratory measurements:

• ALT and AST: enzymes evaluated when assessing liver and tissue-related changes.
• Bilirubin: helps evaluate the processing and elimination of bilirubin.
• Alkaline phosphatase (ALP): provides information relevant to bile-related processes.
• Gamma-glutamyl transferase (GGT): another marker considered during hepatic assessment.

A complete interpretation considers laboratory patterns rather than relying on one isolated enzyme measurement.

This distinction is particularly relevant when evaluating cholestatic patterns associated with anabolic steroids.

Stanozolol and Cholesterol: Understanding Lipid Changes

Another important aspect of stanozolol side effects involves lipid metabolism. Research has examined how this compound influences high-density and low-density lipoproteins.

HDL and LDL participate in cholesterol transport throughout the body. Their concentrations contribute to overall cardiovascular risk assessment.

How Can Stanozolol Influence HDL and LDL?

Some human studies have documented changes in lipid measurements following Stanozolol exposure.

Research involving oral Stanozolol identified reductions in high-density lipoprotein (HDL) cholesterol. Other studies reported changes involving LDL cholesterol and related lipoprotein measurements.

A controlled clinical study involving low-dose Stanozolol also documented significant HDL reductions in treated participants. Follow-up measurements showed movement toward baseline after treatment ended.

These findings provide useful information about stanozolol cholesterol changes and its relationship with lipid metabolism.

Why Is the Lipid Profile Important?

HDL and LDL measurements provide complementary information about cholesterol transport and cardiovascular health.

A lipid profile generally evaluates:

• Total cholesterol.
• HDL cholesterol.
• LDL cholesterol.
• Triglycerides.

Understanding changes in the lipid profile helps clinicians evaluate broader metabolic and cardiovascular considerations.

Individual responses differ, and laboratory results require interpretation alongside personal medical history and other cardiovascular factors.

Stanozolol and Cardiovascular Health

The relationship between stanozolol cardiovascular effects and overall heart health requires examining both compound-specific research and evidence involving anabolic-androgenic steroids as a broader class.

Lipid changes are one important connection. Blood pressure, vascular function, and cardiac structure are additional areas investigated in anabolic steroid research.

Lipid Metabolism and Cardiovascular Function

Changes in HDL and LDL can influence the cardiovascular risk profile. These measurements form part of a broader assessment involving blood pressure and metabolic health.

Research involving anabolic-androgenic steroids has also explored endothelial function, arterial stiffness, and cardiac remodeling.

However, cardiovascular outcome data specifically attributable to Stanozolol remain limited. Broader findings should not automatically be interpreted as precise estimates of individual Stanozolol-related risk.

Blood Pressure and Cardiac Considerations

Blood pressure is an important physiological measurement in cardiovascular evaluation.

Research involving anabolic steroid exposure has identified associations with changes in systolic and diastolic blood pressure. Other studies have examined cardiac structure and vascular function.

The 2025 review Anabolic-Androgenic Steroids Among Recreational Athletes and Cardiovascular Risk discusses these findings across the wider compound class.

These observations highlight the importance of evaluating cardiovascular health through multiple clinical measurements rather than cholesterol alone.

Oral and Injectable Stanozolol: Formulation Differences

Stanozolol has been available in oral and injectable formulations. Both contain the same active compound, although their administration routes differ.

Its 17α-alkylated molecular structure remains relevant when evaluating its pharmacological characteristics.

Injectable administration should not automatically be interpreted as removing hepatic or lipid-related considerations. Research has documented lipid changes following intramuscular Stanozolol administration as well.

Understanding formulation differences therefore requires examining the active molecule, administration route, and available clinical evidence together.

Clinical Monitoring and Medical Context

When examining stanozolol side effects, clinical monitoring provides useful information about liver function, lipid metabolism, and cardiovascular measurements.

The exact assessment depends on individual circumstances and the relevant clinical setting.

Healthcare professionals may consider:

• Liver function measurements, including ALT, AST, ALP, and bilirubin.
• Lipid profile, including HDL, LDL, and triglycerides.
• Blood pressure measurements.
• Relevant medical and medication history.
• Additional cardiovascular investigations when clinically indicated.

Monitoring schedules should reflect individual circumstances rather than a universal testing protocol.

Clinical measurements provide a broader understanding of physiological responses than symptoms alone.

For further educational information about anabolic steroid pharmacology, visit the Vpharma Lab Blog. Our Vpharma Lab catalog also provides general product information, which should be considered separately from independent scientific evidence.

Conclusion: Understanding Stanozolol Side Effects

Stanozolol has a distinctive pharmacological profile involving androgen receptor activity and 17α-alkylation. Current research provides important information about its relationship with liver function and lipid metabolism.

Studies have documented changes in HDL cholesterol and described specific cholestatic liver presentations. Broader anabolic steroid research also provides context for cardiovascular considerations, although compound-specific outcome evidence remains limited.

Understanding these findings requires distinguishing direct Stanozolol research from evidence involving the wider anabolic-androgenic steroid class.

At Vpharma Lab, we aim to explain these compounds through accurate pharmacological information, relevant scientific findings, and balanced clinical context.

Frequently Asked Questions About Stanozolol Side Effects

1. What Is Stanozolol?

Stanozolol is a synthetic anabolic-androgenic steroid derived from dihydrotestosterone. It is commonly associated with the brand name Winstrol.

2. How Does Stanozolol Work?

Stanozolol interacts with androgen receptors and influences biological pathways involved in anabolic activity and protein metabolism.

3. Why Is Stanozolol Classified as a 17α-Alkylated Steroid?

Its molecular structure includes a modification that supports oral activity. This characteristic is also relevant when examining hepatic metabolism.

4. How Does Stanozolol Relate to Liver Function?

Research has documented changes in liver-related laboratory measurements and specific cholestatic presentations. Bilirubin, ALT, AST, ALP, and GGT may contribute to clinical assessment.

5. Can Stanozolol Influence HDL Cholesterol?

Yes. Human studies have documented reductions in HDL cholesterol following Stanozolol exposure. The degree of change varies across studies and clinical settings.

6. What Is the Relationship Between Stanozolol and LDL Cholesterol?

Some research has reported increased LDL cholesterol following Stanozolol administration. Lipid measurements help characterize its metabolic profile.

7. Does Injectable Stanozolol Have a Different Pharmacological Structure?

No. Oral and injectable formulations contain the same active compound. Their administration routes differ, while the molecular structure remains relevant to their pharmacology.

8. Which Cardiovascular Measurements Are Relevant?

Blood pressure and lipid measurements provide useful cardiovascular information. Additional assessments depend on personal medical history and clinical findings.

9. What Is Cholestasis?

Cholestasis refers to altered bile formation or flow. It can influence bilirubin metabolism and is characterized by specific clinical and laboratory findings.

10. What Does Current Research Say About Stanozolol and Cardiovascular Health?

Research has documented lipid-related changes and examined broader cardiovascular effects of anabolic-androgenic steroids. Long-term cardiovascular outcomes specifically attributable to Stanozolol require further investigation.

References and Further Reading

1. NIH LiverTox. Androgenic Steroids: Clinical and Research Information on Drug-Induced Liver Injury.
2. Journal of Clinical and Experimental Hepatology (2025). Stanozolol-Induced Liver Injury: A Distinctive Cholestatic Clinical and Biochemical Phenotype.
3. Journal of the American Academy of Dermatology. Liver Enzymes and Lipid Levels in Patients Treated With Stanozolol: A Controlled Clinical Study.
4. Pharmacology Review (2023). Anabolic-Androgenic Steroids: How Do They Work and What Are the Risks?.
5. Current Opinion in Cardiology (2025). Anabolic-Androgenic Steroids Among Recreational Athletes and Cardiovascular Risk.
6. American College of Cardiology (2024). The Expert’s Approach to Managing Cardiovascular Risk Among Athletes Using Anabolic-Androgenic Steroids.